Imagerie Moléculaire et Stratégies Théranostiques
- Research works
- 53 ▲ 369% vs 2013–17
- Citations
- 713 13.3 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 51% world 28%
Not ranked overall: Imagerie Moléculaire et Stratégies Théranostiques is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.
- Medicine 3.6×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Immunology and Microbiology 2.6×
- Nursing 0.8×
- Physics and Astronomy 0.8×
- Neuroscience 0.6×
- Materials Science 0.3×
- Chemistry 0.2×
- Energy 0.2×
- Engineering 0.1×
- Health Professions 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
Which keywords describe research at Imagerie Moléculaire et Stratégies Théranostiques?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Cancer, Radiotherapy, Dosimetry, PET Imaging, Immunotherapy and Cancer Treatment.
- Inflammation
- Cancer Therapy
- Oxidative Stress
- Radiopharmaceuticals
- Cancer Treatment
- PET Imaging
- Radiotherapy
- Targeted Therapy
- Chemotherapy
- Cancer
- Dosimetry
- Immunotherapy
- Radioimmunotherapy
- Clinical Practice Guidelines
- Prognostic Factors
- Clinical Trials
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Chemotherapy2▲ 15×12 topics
- Targeted Therapy2▲ 45×5 topics
- Cancer2▲ 7.0×17 topics
- Radiotherapy2▲ 23×8 topics
- Dosimetry2▲ 115×2 topics
- PET Imaging2▲ 45×4 topics
- Immunotherapy2▲ 9.8×10 topics
- Cancer Treatment1▲ 28×2 topics
- Radioimmunotherapy1▲ 224×1 topic
- Radiopharmaceuticals1▲ 224×1 topic
- Clinical Practice Guidelines1▲ 10×5 topics
- Oxidative Stress1▲ 3.5×6 topics
- Prognostic Factors1▲ 13×11 topics
- Cancer Therapy1▲ 9.2×11 topics
- Clinical Trials1▲ 7.5×7 topics
- Inflammation1▲ 2.5×16 topics
Which research topics does Imagerie Moléculaire et Stratégies Théranostiques publish most on?
By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Reproductive Biology and Fertility and Sperm and Testicular Function.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 2 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 3 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 1 works
- 4 Sperm and Testicular Function Reproductive Medicine 1 works
- 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 6 Advanced Radiotherapy Techniques Radiation 0 works
- 7 Glioma Diagnosis and Treatment Genetics 0 works
- 8 Cancer Genomics and Diagnostics Cancer Research 0 works
- 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
- 10 Breast Cancer Treatment Studies Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Imagerie Moléculaire et Stratégies Théranostiques's research output changed?
Output in 2018–2022 was 369% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.